GlassScriptPhysician profile
Misty L Wray
NPI 1285640441
$2,657.40
in general payments reported to CMS, 2019-2025
19 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $421 · 2021: $351 · 2022: $226 · 2023: $47.49 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $660.85 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $336.13 | 2019-2021 | |
| Biotissue Holdings INC. | $219.37 | 2021 | |
| Carl Zeiss Meditec, INC. | $210.91 | 2019 | |
| Glaukos Corporation | $159.90 | 2025 | Idosetr |
| Ivantis, INC | $150.38 | 2019 | |
| Abbvie INC. | $127.31 | 2022-2025 | |
| Alcon Vision LLC | $122.60 | 2019-2025 | Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $121.29 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $120.11 | 2019 | |
| Kala Pharmaceuticals, INC. | $115.96 | 2019 | |
| Aerie Pharmaceuticals, INC. | $101.16 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $93.35 | 2022-2023 | Cequa |
| Oyster Point Pharma, INC. | $38.22 | 2022 | |
| Tearlab Corp | $23.39 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $18.89 | 2019 | |
| Dompe US, INC. | $18.65 | 2019 | |
| Shire North American Group INC | $12.71 | 2019 | |
| New World Medical,INC. | $6.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Wray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.